Search
Categories
Hot topics close

Randomized Phase II Stereotactic Ablative Radiation Therapy for ...

Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI).

(UroToday.com) The 2023 American Society of Clinical Oncology (ASCO) annual meeting held in Chicago, IL between June 2nd and June 6th was host to a kidney and bladder cancers poster session. Dr. Rana McKay presented the rationale and study framework for SAMURAI, a randomized phase II trial evaluating stereotactic ablative radiation therapy (SABR) for patients with metastatic, unresected renal cell carcinoma (RCC) receiving systemic immunotherapy. Read More

News Archive
  • Oil
    Oil
    What this Warren Buffett-linked CEO's prediction could mean for Woodside shares
    14 Jun 2024
    2
  • USB flash drive
    USB flash drive
    USB Stick 32 GB Harry Potter – Original Harry Potter 2.0 Flash Drive, Tribe FD037701
    15 Jan 2022
    2
  • Star Diamond
    Star Diamond
    Closing Bell: Star Diamond Corp flat on Wednesday (DIAM)
    16 May 2024
    5
  • Rio Tinto
    Rio Tinto
    Sovereign Metals' Substantial Shareholding Shift - TipRanks.com
    17 Jul 2024
    7
  • Binance
    Binance
    Shytoshi Kusama Issues Crucial BONE Call on Shiba Inu Community: Details
    26 Aug 2024
    31
  • Hulk Hogan
    Hulk Hogan
    Hulk Hogan, 70, marries Sky Daily, 45, in intimate Florida wedding ...
    19 Jul 2024
    4
This week's most popular news